Clinical trial design for the development of new therapies for nonmuscle-invasive bladder cancer: Report of a food and drug administration and american urological association public workshop Conference Paper uri icon

Overview

MeSH Major

  • Clinical Trials as Topic
  • Urinary Bladder Neoplasms

abstract

  • Expert commentary provided by panel members will inform a planned FDA guidance on pathways for drug and biologic development for NMIBC and will be discussed at meetings of the FDA's Oncologic Drugs Advisory Committee. FDA intends to develop a set of principles that can be used to promote the development of new products for this disease.

publication date

  • February 2014

Research

keywords

  • Conference Paper

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.urology.2013.10.030

PubMed ID

  • 24332121

Additional Document Info

start page

  • 262

end page

  • 4

volume

  • 83

number

  • 2